Considering Clinical Trials: An MPN Expert Explains Why Treatment Options Matter With Myelofibrosis

Published on

Topics include: Treatments and Understanding

Dr. Catriona Jamieson, from Moores Cancer Center at UC San Diego Health, joined Patient Power to discuss considerations when choosing to participate in a clinical trial. Dr. Jamieson sheds light on the necessity of ongoing MPN clinical trials, particularly for myelofibrosis, as well as how to talk to your doctor about this treatment option.  

View more programs featuring

Related Programs

Closing the MPN Treatment Gap: An Update on New JAK Inhibitor Trials

Dr. John Mascarenhas, from Mount Sinai School of Medicine, joined Patient Power to discuss the status of JAK inhibitors in clinical trials, particularly pacritinib.


What Does Molecular Remission Mean for MPN Patients?

What is molecular remission in MPNs, and how is it achieved? Dr. Prithviraj Bose from The University of Texas MD Anderson Cancer Center responds.


Join Our Community Register for Events Read Our Latest Blog

Page last updated on August 4, 2017